Oncology Clinical Pharmacology Strategy Transition

Leverage your regulatory expertise to master industry-side dosage optimization and MIDD oversight. This course bridges the gap between FDA review and leading strategic drug development programs. * **Sponsor-side strategy** for oncology drug development programs * **Dosage optimization** using FDA Project Optimus principles * **MIDD oversight** to streamline regulatory approval pathways * **Industry leadership** skills for high-stakes executive interviews

4 sections ยท 9 lessons

Course outline

Dosage Optimization

  1. Project Optimus
  2. Bias Mitigation
  3. Tolerability Metrics

Strategic Planning

  1. Decision Milestones
  2. Integrated Evidence

MIDD Oversight

  1. Model Governance
  2. Diagnostic Critique

Leadership Communication

  1. Decision Memos
  2. Interview Storytelling

Start learning with Wondering